Pharmacy Search
Pharmacy Pharmacy
Most Read Articles
Latest study lifts the fog of vaccine safety
Pearl Toh, 29 Apr 2019
Most of the vaccines routinely recommended in the US are safe with no evidence supporting a causal relationship between the vaccines and adverse events following immunization (AEFIs). Also, most of the AEFIs studied occurred rarely, according to a systematic review presented at the Pediatric Academic Societies (PAS) 2019 Meeting in Baltimore, Maryland, US.
Repeat vaccination safe for patients with mild to moderate reactions
21 Sep 2018
It is safe to revaccinate patients with a history of mild or moderate adverse events following immunization (AEFI), but more research is required in those with serious AEFIs who are less likely to be reimmunized, suggests a recent study.

Product Highlight - Zimilast 1000

20 Nov 2020
The Effective Choice
Against ESBL producing MDR pathogens

- Lower respiratory tract infections
- Urinary tract infections
- Intra-abdominal infections
- Gynecologic infections
- Bacterial septicemia
- Bone and joint infections
- Skin and skin structure infections
- Endocarditis
- Polymicrobial infections

Related MIMS Drugs

ZIMILAST
Editor's Recommendations
Most Read Articles
Latest study lifts the fog of vaccine safety
Pearl Toh, 29 Apr 2019
Most of the vaccines routinely recommended in the US are safe with no evidence supporting a causal relationship between the vaccines and adverse events following immunization (AEFIs). Also, most of the AEFIs studied occurred rarely, according to a systematic review presented at the Pediatric Academic Societies (PAS) 2019 Meeting in Baltimore, Maryland, US.
Repeat vaccination safe for patients with mild to moderate reactions
21 Sep 2018
It is safe to revaccinate patients with a history of mild or moderate adverse events following immunization (AEFI), but more research is required in those with serious AEFIs who are less likely to be reimmunized, suggests a recent study.